{"id":"https://openalex.org/W4411190867","doi":"https://doi.org/10.1016/j.exer.2025.110484","title":"The kallikrein kinin system alters neuroretinal and visual responses in mice","display_name":"The kallikrein kinin system alters neuroretinal and visual responses in mice","publication_year":2025,"publication_date":"2025-06-10","ids":{"openalex":"https://openalex.org/W4411190867","doi":"https://doi.org/10.1016/j.exer.2025.110484","pmid":"https://pubmed.ncbi.nlm.nih.gov/40505713"},"language":"en","primary_location":{"id":"doi:10.1016/j.exer.2025.110484","doi":"https://doi.org/10.1016/j.exer.2025.110484","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.exer.2025.110484","pdf_url":null,"source":{"id":"https://openalex.org/S129637156","display_name":"Experimental Eye Research","issn_l":"0014-4835","issn":["0014-4835","1096-0007"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental Eye Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.exer.2025.110484","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073527313","display_name":"Allen C. Clermont","orcid":"https://orcid.org/0009-0000-5939-5754","observed_orcids":["https://orcid.org/0009-0000-5939-5754"]},"institutions":[{"id":"https://openalex.org/I4210119176","display_name":"KalVista Pharmaceuticals (United States)","ror":"https://ror.org/01rjjd360","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119176"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Allen Clermont","raw_affiliation_strings":["KalVista Pharmaceuticals Inc, Cambridge, MA, USA. Electronic address: ACC@Kalvista.com"],"raw_orcid":"https://orcid.org/0009-0000-5939-5754","affiliations":[{"raw_affiliation_string":"KalVista Pharmaceuticals Inc, Cambridge, MA, USA. Electronic address: ACC@Kalvista.com","institution_ids":["https://openalex.org/I4210119176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001166552","display_name":"Nivetha Murugesan","orcid":"https://orcid.org/0009-0000-4386-5563","observed_orcids":["https://orcid.org/0009-0000-4386-5563"]},"institutions":[{"id":"https://openalex.org/I4210119176","display_name":"KalVista Pharmaceuticals (United States)","ror":"https://ror.org/01rjjd360","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119176"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nivetha Murugesan","raw_affiliation_strings":["KalVista Pharmaceuticals Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KalVista Pharmaceuticals Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210119176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056910741","display_name":"Cheng\u2010mao Lin","orcid":"https://orcid.org/0000-0003-2409-9423","observed_orcids":["https://orcid.org/0000-0003-2409-9423"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cheng-Mao Lin","raw_affiliation_strings":["Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081193362","display_name":"David A. Antonetti","orcid":"https://orcid.org/0000-0003-1130-6577","observed_orcids":["https://orcid.org/0000-0003-1130-6577"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Antonetti","raw_affiliation_strings":["Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042011351","display_name":"Lloyd Paul Aiello","orcid":"https://orcid.org/0000-0003-2012-3465","observed_orcids":["https://orcid.org/0000-0003-2012-3465"]},"institutions":[{"id":"https://openalex.org/I1293231726","display_name":"Joslin Diabetes Center","ror":"https://ror.org/0280a3n32","country_code":"US","type":"facility","lineage":["https://openalex.org/I1293231726"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lloyd P. Aiello","raw_affiliation_strings":["Department of Ophthalmology, Harvard Medical School, Boston, MA, USA; Beetham Eye Institute, Joslin Diabetes Center, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Harvard Medical School, Boston, MA, USA; Beetham Eye Institute, Joslin Diabetes Center, Boston, MA, USA","institution_ids":["https://openalex.org/I1293231726","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026005041","display_name":"Edward P. Feener","orcid":"https://orcid.org/0000-0003-1175-8469","observed_orcids":["https://orcid.org/0000-0003-1175-8469"]},"institutions":[{"id":"https://openalex.org/I4210119176","display_name":"KalVista Pharmaceuticals (United States)","ror":"https://ror.org/01rjjd360","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119176"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward P. Feener","raw_affiliation_strings":["KalVista Pharmaceuticals Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KalVista Pharmaceuticals Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210119176"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5073527313"],"corresponding_institution_ids":["https://openalex.org/I4210119176"],"apc_list":{"value":4010,"currency":"USD","value_usd":4010},"apc_paid":{"value":4010,"currency":"USD","value_usd":4010},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.1434459,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"258","issue":null,"first_page":"110484","last_page":"110484"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.8413000106811523,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.8413000106811523,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.09529999643564224,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10691","display_name":"Retinal Development and Disorders","score":0.04430000111460686,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kallikrein-kinin-system","display_name":"kallikrein-kinin system","score":1.0},{"id":"https://openalex.org/keywords/bradykinin","display_name":"bradykinin","score":0.9900000095367432},{"id":"https://openalex.org/keywords/factor-xiia","display_name":"factor XIIa","score":0.968999981880188},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.800000011920929},{"id":"https://openalex.org/keywords/visual-function","display_name":"visual function","score":0.7549999952316284},{"id":"https://openalex.org/keywords/electroretinography","display_name":"electroretinogram","score":0.9010000228881836},{"id":"https://openalex.org/keywords/optokinetic-reflex","display_name":"optokinetic response","score":0.8090000152587891},{"id":"https://openalex.org/keywords/retinal-vascular-dysfunction","display_name":"retinal vascular dysfunction","score":0.7860000133514404},{"id":"https://openalex.org/keywords/retinal-edema","display_name":"retinal edema","score":0.7379999756813049}],"concepts":[{"id":"https://openalex.org/C52853521","wikidata":"https://www.wikidata.org/wiki/Q423285","display_name":"Kallikrein","level":3,"score":0.6486884951591492},{"id":"https://openalex.org/C2776246183","wikidata":"https://www.wikidata.org/wiki/Q421924","display_name":"Kinin","level":4,"score":0.5583512187004089},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.38737955689430237},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3760964274406433},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.33300164341926575},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2889487147331238},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2856612503528595},{"id":"https://openalex.org/C2779591629","wikidata":"https://www.wikidata.org/wiki/Q24745328","display_name":"Bradykinin","level":3,"score":0.25310271978378296},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22520869970321655},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08052176237106323},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.054095685482025146},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001920","descriptor_name":"Bradykinin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004596","descriptor_name":"Electroretinography","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012160","descriptor_name":"Retina","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012160","descriptor_name":"Retina","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D016234","descriptor_name":"Kallikrein-Kinin System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D017120","descriptor_name":"Nystagmus, Optokinetic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017120","descriptor_name":"Nystagmus, Optokinetic","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.exer.2025.110484","doi":"https://doi.org/10.1016/j.exer.2025.110484","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.exer.2025.110484","pdf_url":null,"source":{"id":"https://openalex.org/S129637156","display_name":"Experimental Eye Research","issn_l":"0014-4835","issn":["0014-4835","1096-0007"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental Eye Research","raw_type":"journal-article"},{"id":"pmid:40505713","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40505713","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental eye research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.exer.2025.110484","doi":"https://doi.org/10.1016/j.exer.2025.110484","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.exer.2025.110484","pdf_url":null,"source":{"id":"https://openalex.org/S129637156","display_name":"Experimental Eye Research","issn_l":"0014-4835","issn":["0014-4835","1096-0007"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental Eye Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F774616873","display_name":"KalVista Pharmaceuticals","ror":"https://ror.org/01rjjd360"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1574902248","https://openalex.org/W1839243089","https://openalex.org/W1897988540","https://openalex.org/W1971512819","https://openalex.org/W1981121080","https://openalex.org/W2006648038","https://openalex.org/W2017523469","https://openalex.org/W2033820137","https://openalex.org/W2052816520","https://openalex.org/W2056275074","https://openalex.org/W2058611989","https://openalex.org/W2067753910","https://openalex.org/W2074317235","https://openalex.org/W2091651333","https://openalex.org/W2095260304","https://openalex.org/W2102719227","https://openalex.org/W2127418688","https://openalex.org/W2132453656","https://openalex.org/W2157900496","https://openalex.org/W2179671136","https://openalex.org/W2263216802","https://openalex.org/W2324588265","https://openalex.org/W2346766681","https://openalex.org/W2483493520","https://openalex.org/W2810004523","https://openalex.org/W2939185314","https://openalex.org/W2954964749","https://openalex.org/W2964209469","https://openalex.org/W2965691495","https://openalex.org/W3013631675","https://openalex.org/W3037629983","https://openalex.org/W3110359981","https://openalex.org/W3123123287","https://openalex.org/W3158522809","https://openalex.org/W3182351737","https://openalex.org/W3185243461","https://openalex.org/W3206798270","https://openalex.org/W4301398089","https://openalex.org/W4389954856","https://openalex.org/W4391617946"],"related_works":["https://openalex.org/W904086568","https://openalex.org/W2346766681","https://openalex.org/W2916254599","https://openalex.org/W2575360447","https://openalex.org/W2791093956","https://openalex.org/W2067036876","https://openalex.org/W3185243461","https://openalex.org/W2993137324","https://openalex.org/W2024953942","https://openalex.org/W4387060293"],"abstract_inverted_index":{"The":[0],"kallikrein-kinin":[1],"system":[2],"(KKS)":[3],"has":[4],"been":[5],"implicated":[6],"in":[7,51,133,146,167,191],"mediating":[8],"both":[9],"VEGF-dependent":[10],"and":[11,16,39,65,71,86,104,109,122,127,173,188],"VEGF-independent":[12],"retinal":[13],"vascular":[14],"dysfunction":[15,200],"edema;":[17],"however,":[18],"little":[19],"is":[20,202],"known":[21],"about":[22],"the":[23,26,34,46,142,164,184,205],"effect":[24],"of":[25,36,45,56,76,98,117,154],"KKS":[27,185],"on":[28,48],"neuroretinal":[29,187],"function.":[30],"This":[31],"study":[32,181],"investigates":[33],"effects":[35],"bradykinin":[37],"(BK)":[38],"Factor":[40],"XIIa":[41],"(FXIIa),":[42],"an":[43,158],"activator":[44],"KKS,":[47],"visual":[49,189,199],"function":[50],"mice.":[52,152,192],"Intravitreal":[53],"injection":[54],"(IVI)":[55],"BK":[57,77],"decreased":[58],"optokinetic":[59],"spatial":[60],"frequency":[61],"by":[62,84,88,107,125,170,175,204],"23%,":[63],"20%":[64],"14%":[66],"(p<0.001)":[67,129,172],"at":[68,92,111],"6,":[69],"12":[70],"24":[72,93,112],"hours,":[73],"respectively.":[74],"IVI":[75,97,116],"increased":[78,100,119],"scotopic":[79,101,120,143],"electroretinogram":[80],"(ERG)":[81],"a-wave":[82,121,168],"amplitudes":[83,106,124],"38%":[85],"b-wave":[87,105,123,174],"40%":[89],"(p<0.01)":[90],"measured":[91],"hours":[94,113],"post":[95,114],"injection.":[96,115],"FXIIa":[99,160,193],"ERG":[102,144],"a-":[103],"44%":[108],"51%":[110],"VEGF":[118],"67%":[126],"71%":[128],"compared":[130],"to":[131],"PBS":[132],"wild":[134],"type":[135],"(WT)":[136],"but":[137],"did":[138],"not":[139],"significantly":[140],"alter":[141],"responses":[145],"FXII":[147],"deficient":[148],"(FXII":[149],"-/-":[150],")":[151],"Pretreatment":[153],"WT":[155],"mice":[156],"with":[157],"oral":[159],"inhibitor,":[161],"KV998086,":[162],"reduced":[163],"VEGF-induced":[165,198],"increase":[166],"amplitude":[169],"99%":[171],"90%":[176],"(p<0.01).":[177],"In":[178],"summary,":[179],"this":[180],"demonstrates":[182],"that":[183,201],"alters":[186],"response":[190],"inhibition":[194],"may":[195],"protect":[196],"from":[197],"mediated":[203],"KKS.":[206]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-10-10T00:00:00"}